Virtual Medicinal Product (VMP) - Brimonidine 3mg/g gel
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Brimonidine 3mg/g gel | Start Date 10-06-2014 | End Date |
| Previous Name | Previous Name Generic Mirvaso gel | Start Date 24-03-2014 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Cutaneous
- Form
- Cutaneous gel
- Ontology Form/Route
- gel.cutaneous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- D11AX21
| BNF | Start Date | End Date |
|---|---|---|
| Current BNF 13060300 | Start Date 04-04-2022 | End Date |
| Previous BNF 13060300 | Start Date 25-06-2014 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 24386811000001104 | 12-03-2014 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Brimonidine tartrate | Based on Base Substance | Brimonidine | 3 mg | 1 gram |
Name
Brimonidine tartrate
Basis of strength description
Based on Base Substance
BOSS
Brimonidine
Strength and UOM (Nmr)
3
Strength and UOM (Dmr)
1
Parent Products
-
VTMBrimonidine
-
VMP(Current) Brimonidine 3mg/g gel
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 30 gram | 3369 | Part VIIIA Category C |